The Elipse Balloon has been widely available in Europe since 2012, though it is in recent years that it has gained tremendous popularity attributed to the many success stories associated with the Elipse Programme and its safety profile.
Total adverse events reported were less than 2% in over 30,000 Elipse Balloons distributed.
(Data from March 2016 – September 2020)
Premature Deflation 0.44%
Intolerance 0.26%
Small Bowel Obstruction 0.09%
Hyperinflation 0.8%
Dysphagia 0.03%
Gastric Outlet Obstruction 0.03%
Gastric Perforation 0.01%
Incomplete Device Emptying 0.01%
Pancreatitis 0.02%
Gastroparesis 0.01%
Share this page:
The Hayloft
Gawsworth Business Court
Shellow Lane
Gawsworth
CW12 2NX
© 2023 All Rights Reserved
Allure Weightloss Limited trading as Allure Weightloss
Company registered in England and Wales No. 12696475.
Registered address: The Hayloft, Gawsworth Business Court, Shellow Lane, Gawsworth CW12 2NX
* “in rare cases the Allurion Balloon may require endoscopic or surgical intervention for removal”. ** “Weight loss results and benefits do vary and are different for each individual”